Comment from University of California system

Summary: The University of California system argues that the proposed guidance incorrectly equates all IND safety reports with "unanticipated problems" requiring IRB reporting. They request that the FDA restore a risk-based filtering approach to prevent IRBs from being overwhelmed by high volumes of non-actionable safety information.